Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1567 of 5804
-
Could a simple inhaler shield lungs during cancer surgery?
Disease control OngoingThis is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery. …
Phase: PHASE3 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New imaging test could spot rare childhood disease sooner
Diagnosis Recruiting nowProspective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluoro…
Phase: PHASE3 • Sponsor: Anna Raciborska • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could an arthritis drug tame OCD? new study investigates
Symptom relief TerminatedThe goal of this study is to examine whether measurements of inflammation from brain scanning and blood tests can predict how much benefit patients with obsessive-compulsive disorder (OCD) will have from treatment with an anti-inflammatory medication, celecoxib, when adding to on…
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New antibody therapy aims to shield kids with rare immune disease from deadly infections
Disease control OngoingThe purpose of this study is to assess efficacy, safety and pharmacokinetics of Kedrion Immunoglobulin 10% (KIg10) in pediatric patients with Primary Immunodeficiency Disease (PID).
Phase: PHASE3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood test could speed up colorectal cancer detection
Diagnosis Recruiting nowColorectal cancer (CRC) is the third most common cancer in men and the second in women with an incidence of 43,350 new cases in 2018. This incidence is increasing every year. Early detection is crucial in this pathology. In France, free screening is organized by health insurance…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New drug SHR-A1811 targets HER2-Positive cancers in early trial
Disease control CompletedThis is a single arm, open-label, dose escalation, PK expansion and efficacy expansion study of phase I. The purpose of this study is to assess the tolerability, safety, pharmacokinetics and immunogenicity of SHR-A1811 and preliminary anti-tumor efficacy in HER2-expressing advanc…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy aims to cut transfusions in MDS patients
Disease control OngoingThis study is a multi-institution, open-label, Phase 1b/2 clinical trial evaluating the toxicity and efficacy of canakinumab in combination with darbepoetin alfa in patients with lower-risk MDS who have failed prior treatment with an Erythropoietin Stimulating Agent (ESA)
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New biologic shows promise for rare inflammatory disease in japan
Disease control CompletedThis study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients with Adult-Onset Still's Disease (AOSD). Interim analysis data collected at Weeks 28 and 48 supported the registration …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Massive genetic study aims to unlock Autism's secrets
Knowledge-focused Recruiting nowThe main objective of the study is to define, for Autism Spectrum Disorder, the extent of genetic variation in synaptic pathways that may be targeted for therapeutic development. For this purpose the investigators will take advantage of large, well-characterized cohorts of patien…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New stomach wrap could improve gastric bypass results and reduce reflux
Disease control CompletedCurrently, one anastomosis gastric bypass (OAGB) or mini-gastric bypass (MGB) is a common bariatric procedure for treating obesity. Weight gain after surgery is a big problem in bariatric practice. Therefore, adjustable bands and rings are used, for example, "FobiRing". But forei…
Phase: NA • Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for giant cell arteritis patients?
Disease control Recruiting nowThis randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing GCA within 8 weeks prior to screening will be randomized at a 1:1 ratio to receiv…
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Robot-Assisted breast surgery: a new hope for High-Risk women?
Disease control OngoingThis study evaluates the safety and effectiveness of the da Vinci Surgical Systems in prophylactic Nipple Sparing Mastectomy procedures.
Phase: NA • Sponsor: Intuitive Surgical • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New devices could revolutionize cervical cancer screening in africa
Diagnosis Recruiting nowThe study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference stan…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Magic mushroom compound tested for Alzheimer's depression
Symptom relief Recruiting nowThis open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocyb…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New pill could help kids with severe psoriasis
Disease control Recruiting nowThe purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in children and adolescent participants aged 4 to \<18 years with moderate to severe plaque psoriasis. This study includes two cohorts; Cohort 1 (age 12 to \<18 years) and C…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Ketogenic diet may offer pain relief for women with lipedema
Symptom relief CompletedLipedema is a female progressive fat disorder, characterized by a symmetrical increase in subcutaneous adipose tissue in the lower extremities with the exception of the waist. The condition is often misdiagnosed and underdiagnosed. The etiology is poorly understood. Affects about…
Phase: NA • Sponsor: Helse Nord-Trøndelag HF • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo shows promise for rare blood cancer
Disease control OngoingThe purpose of this study is to assess the safety, tolerability, and efficacy of BMS-986158 alone and in combination with either Ruxolitinib or Fedratinib in participants with Dynamic International Prognostic Scoring System (DIPSS)-intermediate or high risk blood cancer. Part 1 c…
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a simple pill help ICU patients get off IV blood pressure drugs faster?
Disease control Recruiting nowVasopressors are medications that are given intravenously to increase the blood pressure of patients with illnesses that cause dangerous blood pressure drops. When a doctor prescribes a vasopressor, they ask that the dose be adjusted to achieve a specific blood pressure. This kin…
Phase: PHASE4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study tests ROSE program to stop postpartum depression before it starts
Prevention Recruiting nowThe purpose of this study is to learn more about pregnant women's' experience with Reach Out, Stay Strong, Essentials for mothers of newborns (ROSE) and to evaluate the effectiveness of the ROSE program in preventing and reducing post-partum depressive symptoms, decreasing stress…
Phase: NA • Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New hope for kids with rare sugar disorder: drug shows promise in trial
Disease control CompletedThis study is designed to assess the clinical benefit as well as the safety, pharmacokinetics (PK), and pharmacodynamics (PD) (reduction of galactitol levels) of AT-007 in pediatric subjects with Classic Galactosemia (CG).
Phase: PHASE2, PHASE3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC